Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Understand why the SP 500 garners so much attention from investors. A brief look at liquidity, breadth, and what movers it signals.
20,952 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
Longbridge Financial has rolled out RetentionIQ, a program to protect broker-originated loan pipelines from direct re...
Binance adds CFG to three spot markets, sparking a rapid, 63% price spike for Centrifuge. The move highlights how exc...
Solana’s stablecoin liquidity reached a new peak in February 2026, while open interest rose to near $6 billion, signa...
Bond markets show renewed stress, with yields rising and liquidity thinning. Analysts say a familiar pattern is reeme...
Prosecutors are reviewing a retrial letter from Sam Bankman-Fried after irregularities in a FedEx shipment and a misl...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...
Federal rules demanding domestic-made materials for affordable housing funded with federal dollars are slowing projec...
A viral Met Gala moment isn't just fashion news. It can ripple into earnings, sponsorships, and long-term financial p...
Can Meta be a profitable addition to your portfolio? This guide weighs AI progress, cash flow, and valuation signals ...
Cotality unveiled its Broker Listing Exchange (BLX), with Keller Williams and HomeServices of America as the first ad...